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Summary
A dynamic treatment regime effectively incorporates both accrued information and
long-term effects of treatment from specially designed clinical trials. As these become
more and more popular in conjunction with longitudinal data from clinical studies, the
development of statistical inference for optimal dynamic treatment regimes is a high
priority. This is very challenging due to the difficulties arising form non-regularities
in the treatment effect parameters. In this paper, we propose a new reinforcement
learning framework called penalized Q-learning (PQ-learning), under which the non-
regularities can be resolved and valid statistical inference established. We also propose
a new statistical procedure—individual selection—and corresponding methods for
incorporating individual selection within PQ-learning. Extensive numerical studies
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are presented which compare the proposed methods with existing methods, under a
variety of non-regular scenarios, and demonstrate that the proposed approach is both
inferentially and computationally superior. The proposed method is demonstrated
with the data from a depression clinical trial study.
Keywords: Dynamic treatment regime; individual selection; multi-stage; non-regularity;
penalized Q-learning; Q-learning; shrinkage; two-stage procedures.
1 Introduction
Developing effective therapeutic regimens for diseases is one of the essential goals of
medical research. Two major design and analysis challenges in this effort are: taking
accrued information into account in clinical trial designs and effectively incorporating
long-term benefits and risks of treatment due to delayed effects. One of the most
promising approaches to deal with these two challenges has been recently referred to
as “dynamic treatment regimes” or “adaptive treatment strategies” (Murphy, 2003),
and the method has been utilized in a number of settings, such as drug and alcohol
dependency studies.
Reinforcement learning—one of the primary tools used in developing dynamic
treatment regimes— is a sub-area of machine learning, where the learning behavior
is through trial-and-error interactions with a dynamic environment (Kaelbling et al.,
1996). Because reinforcement learning techniques have been shown to be effective in
developing optimal dynamic treatment regimes, the area is attracting increased at-
tention among statistical researchers. As a recent example, a new approach to cancer
clinical trials based on the specific area of reinforcement learning called Q-learning,
has been proposed by Zhao et al. (2009). Extensive statistical estimating methods
have also been proposed for optimal dynamic treatment regimes, including, for ex-
ample, Chakraborty et al. (2009), who developed a Q-learning framework based on
linear models. Other related literature includes likelihood-based methods (both fre-
quentist and Bayesian) by Thall et al. (2000, 2002, 2007) and semiparametric methods
by Lunceford et al. (2002); Murphy (2003); Robins (2004), Wahed and Tsiatis (2006,
2004), Moodie et al. (2009) and Moodie and Stephens (To appear).
In contrast to the substantial body of estimating methods, the development of sta-
tistical inference for optimal dynamic treatment regimes is very limited and far from
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ready. This sequential, multi-stage decision making problem is at the intersection of
machine learning, optimization and statistical inference and is thus quite challenging.
As discussed in Robins (2004), and recognized by many other researchers, the key
difficulty lies in the fact that the treatment effect parameters at any stage prior to
the last stage may be non-regular for certain longitudinal distributions of the data,
where non-regularity in this instance means that the asymptotic distribution of the
estimator of the treatment effect parameter does not converge uniformly over the
parameter space (Chakraborty et al., 2009).
This non-regularity arises when the optimal last stage treatment is non-unique
for at least some subjects in the population, causing estimation bias and failure of
traditional inferential approaches. There have been a number of proposals for correct-
ing this problem. For example, Moodie and Richardson (2010) proposed a method
called Zeroing Instead of Plugging In (ZIPI). This method is also referred to as the
hard-threshold estimator by Chakraborty et al. (2009). Chakraborty et al. (2009)
also proposed a soft-threshold estimator and implemented several kinds of bootstrap
methods. Both the hard-threshold estimator and the soft-threshold estimator essen-
tially shrink the “problematic” term to decrease the degree of non-regularity. While
this intuitively makes sense, there is, however, a lack of theoretical support for these
methods. Moreover, extensive simulation studies in their associated papers indicate
that neither hard-thresholding nor soft-thresholding, in conjunction with their boot-
strap implementation, works uniformly well for all simulation settings. We are there-
fore motivated to develop improved, asymptotically valid estimation and inference for
optimal dynamic treatment regimes.
In this paper, we develop a new reinforcement learning framework for discovering
optimal dynamic treatment regimes: Penalized Q-learning (abbreviated hereafter as
PQ-learning). This new backward recursive multistage learning approach can be
viewed as a penalized version of Q-learning. The major distinction of the proposed
PQ-learning from traditional Q-learning is in the form of the objective Q-function at
each stage. While the proposed method shares many of the properties of traditional
Q-learning, there are at least three significant advantages which we now describe.
First, the notorious and inevitable non-regularity issue associated with Q-learning
can be resolved with PQ-learning. At each stage of Q-learning, the maximization
functional over individual treatments are involved, hence there is at least one non-
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differentiable point over the range of the treatment parameters. If the probability
mass on this point is positive, i.e., some individuals have no treatment effects, it will
cause non-ignorable non-regularity issues that will yield failure of existing inferential
methods. With PQ-learning, all individuals experiencing no treatment effect can be
identified with probability converging to one, as in the oracle setting.
Second, we propose effective inferential procedures based on PQ-learning for op-
timal dynamic treatment regimes. In contrast to existing bootstrap approaches, our
variance calculations are based on explicit formula and hence are much less time-
consuming. Thorough theoretical studies and extensive empirical evidence both sup-
port the validity of the proposed methods.
Third, since PQ-learning puts a penalty on each individual, it automatically ini-
tiates another important statistical procedure: individual selection. The purpose
of individual selection is to select those individuals without treatment effects from
the population. Successful individual selection, i.e., correctly identifying individuals
without treatment effects, is the key to resolving the non-regularity problem.
Besides improving statistical inference, individual selection is itself an important
task in identifying optimal dynamic treatment regimes and in many biomedical and
clinical studies. If individuals without treatment effects can be correctly identified,
then the corresponding components of the history of these individuals potentially
need not be collected to make decisions using the optimal dynamic treatment regime.
This could significantly reduce the cost of data collection during implementation
of the optimal dynamic treatment regime. While the proposed individual selection
procedure shares some similarities with certain commonly used variable selection
methods, the approaches are fundamentally different in other ways. These issues
will be addressed in greater detail in the paper.
The remainder of the paper is organized as follows. In Section 2, we provide
a review of statistical problems in reinforcement learning. The proposed penalize
Q-learning and individual selection procedure are presented in Section 3, where the
implementation and the statistical properties are discussed in detail. Some empirical
results are presented in Section 4. We apply the proposed approach to the Sequenced
Treatment Alternatives to Relieve Depression (STAR*D) clinical trial in Section 5.
A summary of our findings with a discussion is given in Section 6. Proofs are deferred
to the Appendix.
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2 Statistical Problems in Reinforcement Learning
2.1 Reinforcement Learning
The basic reinforcement learning procedure involves
i trying and recording a sequence of actions,
ii statistically estimating the relationship between the actions and consequences
and
iii choosing the action that results in the most desirable consequence based on
statistical decisions.
A detailed introduction of reinforcement learning can be found in Sutton and Barto
(1998). In a reinforcement learning based clinical trial design, we choose a sequence
of actions applied to the patient and the environment responds to those actions and
provides feedback. Here, “environment” refers to the system consisting of the human
body and related additional sources of measurements. Specifically, we use random
variable S to denote the set of environmental states and A to denote the set of possible
actions. For example, states can represent individual patient prognostic factors and
actions can represent different treatment agents or dose levels. Their time-dependent
versions are denoted St = {S0, S1, . . . St} andAt = {A0, A1, . . . , At}, respectively. We
use the corresponding lower case to denote a realization of these random variables
and random vectors. The time points correspond to clinical decision points in the
course of patient treatment. After each time step t, as a consequence of a patient’s
treatment, the patient receives a numerical reward, denoted with a random variable
Rt, which can be represented as a function R(·) of the current state St, current action
At and next state St+1, that is, Rt = R(St,At, St+1). We also denote a realization of
Rt as rt = R(st, at, st+1).
Within a reinforcement learning framework, an exploration policy pi can be rep-
resented as pit(st, at−1) = at, a mapping from state st and action at−1 to the set of
possible actions. In the clinical setting, a policy is a treatment regimen or a rule.
Since our goal in the clinical setting focuses on discovering the treatment that yields
a maximized long term reward for the patient, i.e., an optimal personalized treatment,
thus seeking the optimal policy that maximizes the expectations of the total rewards
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over the time trajectories is a major goal of clinical research. Accordingly, we define
a value function as a function of states and actions:
Vt(st, at−1) = Eπ
[ U∑
k=0
γkrt+k
∣∣∣St = st,At−1 = at−1],
where the discount rate γ ∈ [0, 1] can be interpreted as a control to balance a patient’s
immediate reward and future rewards. The value function measures the success of
the treatment policy pi. Letting Π denote the set of all policy candidates, the optimal
value function can be defined as V ⋆t (st, at−1) = maxπ∈Π Vt(st, at−1).
The value functions used in reinforcement learning typically satisfy the recursive
Bellman equation (Bellman, 1957), which forces the optimal policy pi⋆t to satisfy
pi⋆t (st, at−1) ∈ argmaxatE
[
rt + γV
⋆
t+1(St+1,At)
∣∣∣St = st,At−1 = at−1].
Due to computational challenges, it is usually not possible to directly compute an
optimal policy by directly solving the Bellman equation. As an alternative method
which requires less memory and less computation, temporal-difference learning can
also be used to obtain optimal policies (Kaelbling et al., 1996; Sutton, 1988). In the
next section, we will introduce a very important off-policy temporal-difference learn-
ing method, Q-learning, which is a popular approach to estimate dynamic treatment
regimes. Q-learning is the estimating approach for which the statistical inference
procedures in Chakraborty et al. (2009) were proposed.
2.2 Q-Learning Procedure
The motivation of Q-learning is that once the Q-functions have been estimated, it
is only necessary to know the state to determine the best action. From a statistical
perspective, the optimal time-dependent Q-function is
Q⋆t (st, at) = E
[
rt + γV
⋆
t+1(St+1,At)
∣∣∣St = st,At = at].
Since by definition, V ⋆t+1(st+1, at) = maxat+1 Q
⋆
t+1(st+1, at, at+1), and hence
pi⋆t+1(st+1, at) = argmaxat+1Q
⋆
t+1(st+1, at, at+1), one-step Q-learning thus has the sim-
ple recursive form:
Qt(st, at) = E
[
Rt + γmax
at+1
Qt+1(St+1, at+1)
∣∣∣St = st,At = at]. (1)
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According to the recursive form of Q-learning in (1), we must estimate Qt backwards
through time t = U, U − 1, . . . , 0. To estimate each Qt, we parameterize Qt(st, at; θt)
as a function of the parameter θt. After finishing estimation through this backward
recursive process and obtaining the sequence estimators {Q̂t}Ut=0, we can estimate the
optimal treatment regimes pit = argmaxatQ̂t(st, at; θt), for t = 1, . . . , U.
We will use a simple, two-stage example (also used in Chakraborty et al. (2009))
to illustrate the proposed approaches. Let the Q-function for time t = 1, 2 be modeled
as
Qt(St, At;βt,ψt) = β
T
t St1 + (ψ
T
t St2)At, (2)
where St is the full state information at time t and St1 and St2 are subsets of St
selected for the model. The action At takes value 1 or −1. The parameters of
the Q-function are θt = (β
T
t ,ψ
T
t )
T , where βt reflects the main effect of current
state on outcome, while ψt reflects the interaction effect between current state and
treatment choice. Let Yt denote the optimal total potential reward at time t. In
this work, we will assume that Y2 = R2, the discount rate γ = 1 and Y1 = R1 +
maxa∈{−1,1}Q2(S2, a;β20,ψ20), where β20 and ψ20 are the true unknown values. The
observed data consist of (Sti, Ati, Rti) for patients i = 1, . . . , n and t = 1, 2, from a
sample of n patient trajectories.
The two-stage empirical version of the Q-learning procedure can now be summa-
rized as follows:
Step 1. Start with a regular and non-shrinkage estimator, based on least squares, for
the second stage:
θ̂2 = (β̂
T
2 , ψ̂
T
2 )
T = argminβ
2
,ψ
2
Pn(Y2 −Q2(S2, A2;β2,ψ2))2 =
[
ZT2Z2
]−1
ZT2Y2,
where Z2 is the stage-2 design matrix and Y2 = (Y21, ..., Y2n)
T and Pnf(x) =
1/n
∑n
i=1 f(xi) is the empirical measure.
Step 2. Estimate the first-stage individual pseudo-outcome by Ŷ
HM
1 = (Ŷ
HM
11 , . . . , Ŷ
HM
1n )
T ,
where
Ŷ HM1i = R1i +maxaQ2(S2i, a; β̂2, ψ̂2) = R1i + β̂
T
2 S21i + |ψ̂
T
2 S22i|. (3)
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Step 3. Estimate the first-stage parameters by least square estimation:
θ̂
HM
1 = argminβ
1
,ψ
1
Pn(Ŷ
HM
1 −Q1(S1, A1;β1,ψ1))2 =
[
ZT1Z1
]−1
ZT1 Ŷ
HM
1 ,
where Z1 is the stage-1 design matrix. The corresponding estimator of ψ1,
denoted by ψ̂
HM
1 , is referred to as the hard-max estimator in Chakraborty et al.
(2009), because of the maximizing operation used in the definition.
2.3 Non-regularity Problem in Statistical Inference
When the Q-function is taking the linear model form (2), the optimal dynamic treat-
ment regime for patient {i, i = 1, . . . , n} is given by
di(Sji) = argmaxai(ψ
T
j Sj2i)ai = sgn(ψ
T
j Sj2i), for j = 1, 2,
where sgn(x) = 1 if x > 0 and −1 otherwise. The parameters ψ2 are of particular
interests for estimation and inference of the optimal dynamic treatment regime, as
confidence intervals for ψj can lead to confidence intervals for di.
During the Q-learning procedure, when there is a positive probability thatψT20S22 =
0, the first-stage hard-max pseudo-outcome Ŷ
HM
1 is a non-smooth function of ψ̂2. As
a linear function of Ŷ
HM
1 , the hard-max estimator ψ̂
HM
1 is also a non-smooth function
of ψ̂2. Consequently, the asymptotic distribution of
√
n(ψ̂
HM
1 −ψ10) is neither nor-
mal nor any well-tabulated distributions if P (ψT20S22 = 0) > 0. In this non-standard
case, standard inference methods such as Wald-type confidence intervals are no longer
valid.
2.4 Review of Existing Approaches
To overcome the difficulty of inference of ψ1 due to non-regularity in Q-learning,
several methods have been proposed and we will briefly review these methods in the
two-stage set-up. They are referred to as the hard-threshold estimator (also called
Zeroing Instead of Plugging In (ZIPI) estimator in Moodie and Richardson (2010) and
the soft-threshold estimator in Chakraborty et al. (2009). Since all these methods are
also nested in the Q-learning procedure, we update the two-stage version of Q-learning
as follows:
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Step 2’. Estimate the first-stage individual pseudo-outcome by shrinking the second-
stage regular estimators via hard-thresholding or soft-thresholding. Specifically,
the hard-threshold pseudo-outcome is denoted Ŷ
HT
1 = (Ŷ
HT
11 , . . . , Ŷ
HT
1n )
T , with
Ŷ HT1i = R1i + β̂
T
2 S21i + |ψ̂
T
2 S22i| · 1
{ √n|ψ̂T2 S22i|√
ST22iΣ̂2S22i
> zα/2
}
, (4)
where Σ̂2 is the estimated covariance matrix of ψ̂2.
The soft-threshold pseudo-outcome is denoted Ŷ
ST
1 = (Ŷ
ST
11 , . . . , Ŷ
ST
1n )
T , with
Ŷ ST1i = Y1i + β̂
T
2 S21i + |ψ̂
T
2 S22i|
(
1− λi
|ψ̂T2 S22i|
)+
, i = 1, . . . , n, (5)
where x+ = xI{x > 0} is the positive part of a function and λi is a tuning
parameter.
Step 3’. Estimate the first-stage parameters by least squares estimation:
θ̂
T
1 = (β̂
T
1 , ψ̂
T
1 )
T = argminβ
1
,ψ
1
Pn(Ŷ
◦
1 −Q1(S1, A1;β1,ψ1))2 =
[
ZT1 Z1
]−1
ZT1 Ŷ
◦
1,
where Ŷ
◦
1 = (Ŷ
◦
11, ..., Ŷ
◦
1n)
T is the first-stage pseudo-outcome obtained in Step 2’.
It can be either a hard-threshold or soft-threshold pseudo-outcome, as defined in
either (4) or (5), respectively. The corresponding estimator of ψ1, denoted ψ̂
◦
1,
can be the hard-threshold estimator ψ̂
HT
1 (also referred to as Zeroing Instead
of Plugging (ZIPI) estimator in Moodie and Richardson (2010)) or the soft-
threshold estimator ψ̂
ST
1 , respectively.
The hard-thresholding and soft-thresholding methods can be viewed as upgraded
versions of the hard-max methods in terms of reducing the degree of non-regularity.
For example, Chakraborty et al. (2009) commented that the third term in (5) takes
the form of the non-negative garrote estimator (Breiman, 1995), through which the
problematic term |ψ̂T2 S22| is expected to shrink (or thresholded) towards zero. Even
if the degree of non-regularity is somewhat decreased, in general, ψ̂
HT
1 and ψ̂
ST
1
remain non-regular estimators of ψ10, and standard inference methods such as Wald-
type confidence intervals are still not valid. Numerical studies in Chakraborty et al.
(2009) show an apparent bias for these two methods in certain simulation settings.
Due to the nature of the non-regularity, the asymptotic distributions of these three
estimators are not well tabulated, and thus direct inference for ψ1 is not feasible.
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Bootstrap methods seem to be the only remedy. Chakraborty et al. (2009) applied
several bootstrap methods to construct confidence interval for ψ1. Unfortunately, no
theoretical support was provided for any of these methods. Moreover, none of these
bootstrap confidence intervals for hard-thresholding and soft-thresholding methods
perform uniformly well in all of the simulation scenarios considered.
In summary, the first-stage pseudo-outcome for these three existing methods can
be viewed as shrinkage functionals of certain standard estimators (such as least square
estimator in this two-stage set-up). Although the idea of simultaneously approxi-
mating the hard-max estimator (or more precisely, the absolute value function) and
reducing the degree of non-regularity sounds reasonable, it may not be an appro-
priate approach to use shrinkage formulations of existing regular estimators directly
as the first-stage pseudo-outcome. The reason is that even if these estimators form
shrinkage estimators under certain conditions (e.g., least squares regression with the
only covariates S21 and under an orthonormal design), in general, they are not opti-
mizers of reasonable objective functions. Consequently, even if these estimators can
successively achieve the goal of shrinkage, the following two drawbacks remain that
negate their ability to be used for statistical inference for optimal dynamic treatment
regimes.
First, the bias of these “shrinking” first-stage pseudo-outcomes can be large in
finite samples, leading to further bias in the first stage estimation of ψ1. This point
has been demonstrated in the empirical studies of Chakraborty et al. (2009). Second,
and more importantly, these shrinking functional estimators do not appear to possess
the oracle property. Here we refer to the oracle property as: with probability tending
to one, the set M⋆ = {i : |ψT20S22i| > 0} can be correctly identified and the resulting
estimator performs as well as the oracle estimator, which knows in advance the right
setM⋆. These two concerns probably are the direct reasons why these three existing
estimation methods, with their corresponding bootstrapping confidence intervals, do
not perform well (with bias and invalid coverage length, for example) in some em-
pirical studies. This suggests that it may not be appropriate to attempt to fix the
non-regularity by regularizing existing estimators directly.
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3 Inference Based on Penalized Q-Learning
In this section, we propose an innovative method, penalized Q-learning (PQ-learning),
for statistical inference in reinforcement learning problems. Our method is based on
individual selection via a penalized likelihood; so it will automatically determine those
individuals whose value functions are not affected by treatment assignments, i.e, those
individuals for whom ψT2 S22 given in Section 2.2 is 0. As a result, this oracle property
ensures that subsequent inference in the Q-learning framework will be the same as
if we knew which individuals had no treatment effect. Accordingly, the resulting
inference will no longer suffer from the non-regularity problem discussed above. To
describe our method, we still focus on the two-stage setting as given in Section 2.2
and use the same notation. The generalization to the multiple-stage setting is similar
and we will it discuss briefly at the end of the section.
3.1 Estimation Procedure
As a backward recursive reinforcement learning procedure, our method follows es-
sentially the same three steps as the usual Q-learning method. The only difference
is that our approach replaces Step 1 of the standard Q-learning procedure with the
following:
Step 1’. Instead of minimizing the summed squared differences between Y2 andQ2(S2, A2;β2,ψ2),
we minimize the following penalized objective function:
W2(θ2) =
n∑
i=1
(Y2i −Q2(S2i, A2i;β2,ψ2))2 +
n∑
i=1
pλn(|ψT2 S22i|), (6)
where pλn(·) is a pre-specified penalty function and λn is a tuning parameter.
Because of this penalized estimation, we call our approach “penalized Q-learning”
and abbreviate it as PQ-learning. Since the penalty is put on each individual, we also
call Step 1’ “individual selection.”
Using penalty functions in PQ-learning, i.e., individual selection, enjoys simi-
lar “shrinkage” advantages as penalized methods described in the recent variable
selection literature. To name a few, the bridge regression in Frank and Friedman
(1993), the LASSO in Tibshirani (1996), the SCAD and other folded-concave penal-
ties in Fan and Li (2001), the Dantzig selector in Candes and Tao (2007), the adaptive
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LASSO in Zou (2006) and one-step estimator in Zou and Li (2008). In variable se-
lection problems where the selection of interest consists of the important variables
(mostly covariates) with nonzero coefficients, using appropriate penalties can shrink
the small estimated coefficients to zero to enable the desired selection. In the individ-
ual selection done in the first step of the proposed PQ-learning approach, penalized
estimation allows us to simultaneously estimate the second-stage parameters θ2 and
select individuals whose value functions are not affected by treatments, i.e., those
individuals whose true values of ψT2 S22 are zero.
The above fact is extremely useful in making correct inference in the subsequent
steps of the PQ-learning procedure. To understand why, we recall that the non-
regularity problem in the usual Q-learning procedure is mainly caused by difficulties
in obtaining the correct asymptotic distribution of
√
n(|ψ̂T2 S22| − |ψT20S22|),
where ψ20 is the true value of ψ2. Via our PQ-learning method, we can identify
individuals whose ψ̂2S22 = ψ
T
20S22 takes value zero; moreover, we know that for these
individuals ψ̂
T
2 S22 has the same sign as ψ
T
20S22. In this case, the above expression is
equivalent to
√
n(ψ̂2 −ψ20)TS22sign(ψT0 S22).
Hence, correct inference can be obtained following standard arguments. More rigorous
details will be given in our subsequent asymptotic theorems and proofs.
The choice of the penalty function pλn(·) can be taken to be the same as used
many popular variable selection methods. Specifically, we require pλn(·) to possess
the following properties:
A1. For non-zero fixed θ, limn→∞ n
1/2pλn(|θ|) = 0, limn→∞ n1/2p′λn(|θ|) = 0,
and {pλn ′′(|θ|)} → 0.
A2. For any M > 0, limn→∞ inf |θ|≤Mn−1/2 pλn(|θ|)→∞.
Among many penalty functions satisfying A1 and A2, some common choices include
the SCAD penalty (Fan and Li, 2001) and the adaptive lasso penalty (Zou, 2006),
where pλn(θ) = λnθ/|θ(0)|α with α > 0 and θ(0) being a root-n consistent estimator of
θ. To achieve both sparsity and oracle properties, the tuning parameter λn in these
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examples should be taken correspondingly. For illustration, Figure 1 plots these
penalty functions. The adaptive lasso method will be implemented in this paper,
where λn can be taking as scalars satisfying
√
nλn → 0 and nλn →∞.
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Figure 1: Plot of thresholding functions with λ=2 for (a) the Hard Threshold;
(b)adaptive lasso with α = 3; (c) SCAD, with the hard-max function as a reference
in each panel.
3.2 Implementation
The minimization in Step 1’ of the PQ-learning procedure has some unique features
which distinguish it from the optimization done in the variable selection literature.
First, the component to be shrunk, ψT2 S22i, is subject-specific; second, this component
is a hyperplane in the parameter space, i.e, a linear combination of the parameters.
To deal with these issues, in this section, we propose an algorithm for the minimiz-
ing problem of (6) based on local quadratic approximation (LQA). Following Fan and
Li (2001), we first calculate an initial estimator ψ̂2(0). We then obtain the following
LQA to the penalty terms in (6):
pλn(|ψT2 S22i|) ≈ pλn(|ψ̂
T
2(0)S22i|) +
1
2
p′λn(|ψ̂
T
2(0)S22i|)
|ψ̂T2(0)S22i|
((ψT2 S22i)
2 − (ψ̂T2(0)S22i)2)
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for ψ2 close to ψ̂2(0). Thus, (6) can be locally approximated up to a constant by
n∑
i=1
(Y2i −Q2(S2i, A2i;β2,ψ2))2 +
1
2
n∑
i=1
p′λn(|ψ̂
T
2(0)S22i|)
|ψ̂T2(0)S22i|
(ψT2 S22i)
2. (7)
The updated estimators for ψ2 and β2 can be obtained by minimizing the above
approximation. Under the special case where Q(·) is given by (2), this minimization
problem has a closed form solution:
ψ̂2 =
[
XT22(I−X21(XT21X21)−1XT21 +D)X22
]−1
XT22(I−X21(XT21X21)−1XT21)Y2,
β̂2 = (X
T
21X21)
−1XT21(Y2 −X22ψ̂2),
where X22 is a matrix with i-th row equal to S
T
22iA2i, X21 is a matrix with i-th row
equal to ST21i, I is the n× n identity matrix and D is an n× n diagonal matrix with
Dii =
1
2
p′λn(|ψ̂
T
2(0)S22i|)/|ψ̂
T
2(0)S22i|.
The above minimization procedure can be continued for more than one step or
until convergence. However, as discussed in Fan and Li (2001), either the one-step
or k-step estimator will be as efficient as the fully iterative method as long as the
initial estimators are good enough. A well known limitation of the LQA algorithm
is that although it can shrink |ψ̂T2 S22i| to a very small value if the true value is zero,
it cannot set it exactly to zero. Therefore, in practice, we will set |ψ̂T2 S22i| = 0 once
the value is below a pre-specified tolerance threshold.
The choice of LQA is mainly for convenience in solving the penalized least squares
estimation in (6). If least absolute deviation estimation or some other quantile re-
gressions is used in place of least squares, then the local linear approximation of the
penalty function described in Zou and Li (2008) can be used instead of LQA, and the
resulted minimization problem can be solved by linear programming. The linear pro-
gramming approach can shrink small values of |ψ̂T2 S22i| exactly to zero and therefore
avoids the additional thresholding done in LQA. Alternatively, the Dantzig selector
(Candes and Tao, 2007) can be used with penalized least squares estimation in (6),
but the asymptotic properties for this setting are beyond the scope of this paper,
although they are currently being investigated by the authors.
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3.3 Asymptotic Results
In this section, we establish the asymptotic properties for the parameter estimators in
our PQ-learning method, assuming that the support of S22 contains a finite number of
vectors, say, T1, ...,TK . Moreover, we assume ψ
T
20Tk 6= 0 for k ≤ K1 and ψT20Tk = 0
for k > K1. Let
nk = #|{i : S22i = Tk, i = 1, . . . , n}|,
where for a set A, #|A| is defined as its cardinality.
Additionally, we assume that the penalty function pλn(x) satisfies A1 and A2 and
that the following conditions hold:
B1. The true value for θ2, denoted by θ20 = (ψ
T
20,β
T
20)
T , minimizes
lim
n
Pn [Y2 −Q2(S2, A2;β2,ψ2)]2 ;
while, the true value for θ1, denoted by θ10 = (ψ
T
10,β
T
10)
T , minimizes
lim
n
Pn
[
R1 +max
a
Q2(S2, a;β20,ψ20)−Q1(S1, A;β1,ψ1)
]2
.
In both expressions and in the following, we always assume that the limits exist.
B2. For k = 1, 2, with probability one, Qk(Sk, Ak; θk) is twice-continuously differen-
tiable with respect to θk in a neighborhood of θk0 and moreover, the eigenvalues
of the Hessian matrix, Ik0 ≡ limn Pn[∇2θkθk(Yk −Qk(Sk, Ak; θk))
2], are positive
and bounded away from zero at θk = θk0.
B3. With probability one, nk/n = pk +Op(n
−1/2) for some constant pk in [0, 1].
Condition B1 basically says that θ10 and θ20 are the target values in the dynamic
treatment regimes, which we consider to be the true values. Condition B2 can be
verified via the design matrix in the two-stage setting. Specifically, ifQt takes the form
of (2), this condition is equivalent to non-singularity of the design matrix [At,StAt].
Under these conditions, our first theorem shows that in Step 1’ of the PQ-learning
procedure, there exists a consistent estimator for θ2:
Theorem 1. Under conditions A1-A2 and B1-B3, there exists a local minimizer
θ̂2 ofW2(θ2) such that ‖θ̂2−θ20‖ = OP (n−1/2+an), where an = maxK1k=1
{
p′λn(|ψT20Tk|)
}
.
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According to the properties of pλn(·), we immediately conclude that θ̂2 is
√
n-
consistent. From Theorem 1, we further obtain the following result, which verifies
the oracle property of the penalized method:
Theorem 2. Recall the set
Mc⋆ =
{
i : ψT20S22i = 0
}
.
Then under conditions A1-A2 and B1-B3,
lim
n→∞
P (ψ̂
T
2 S22i = 0, for any i ∈Mc⋆) = 1.
The set Mc⋆ consists of those individuals whose true value functions at the first
stage have no effect from treatment. Thus Theorem 2 states that with probability
tending to one, we can identify these individuals inMc⋆ using empirical observations.
As discussed before, this result will be very useful in addressing the non-regularity
problem for subsequent inference. Additionally, we will also need the asymptotic dis-
tribution of θ̂2 in order to make inference. This is provided in the following theorem:
Theorem 3. Under conditions A1-A2 and B1-B3,
√
n(I20 + Σ){θ̂2 − θ20 + (I20 + Σ)−1b} → N{0, I20}, (8)
where
b =
(
0Tp ,
K1∑
k=1
pkp
′
λn(|ψT20Tk|)sgn(ψT20Tk)TK
)T
,
and Σ = diag{0p×p,
K1∑
k=1
pkp
′′
λn(|ψT20Tk|)TkTTk }.
Using the results from Theorems 1–3, we are able to establish asymptotic normal-
ity of the first stage estimator θ̂1:
Theorem 4. Under conditions A1-A2 and B1-B3, let S¯2 ≡ (ST21,ST22sgn(ψT20S22))T .
Then
√
n(θ̂1 − θ10)→ I−110
{
G1 + lim
n
PnZ1S¯
T
2G2
}
, (9)
where G1 ∼ N
[
0, limn cov
{
∇θ1Q1(S1, A1; θ10)(Y1 −Q1(S1, A1; θ10))
}]
,
G2 ∼ N
[
0, (I20 + Σ)
−1I20(I20 + Σ)
−1
]
and cov represent the sample variance.
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3.4 Variance Estimation
The standard errors for the estimated parameters can be obtained directly since we
are estimating parameters and selecting individuals simultaneously. A sandwich type
plug-in estimator can be used as the variance estimator for θ̂2:
ĉov(θ̂2) = (Î20 + Σ̂)
−1Î20(Î20 + Σ̂)
−1,
where Î20 ≡ Pn[∇2θ2θ2(Y2 − Q2(S2, A2; θ2))
2] is the empirical Hessian matrix and
Σ̂ = diag{0p×p,Pnp′′λn(|ψ̂
T
2 S22|)S22ST22}. As Σ̂ is often negligible, we use
ĉov(θ̂2) = Î
−1
20 (10)
instead, and this performs well in practice. The estimated variance for θ̂1 is then
ĉov(θ̂1) =
Î−110
[
cov
{
∇θ1Q1(S1, A1; θ̂1)(Y1 −Q1(S1, A1; θ̂1))
}
+ PnZ1S¯
T
2 ĉov(θ̂2)S¯2Z
T
1
]
Î−110 , (11)
where Î10 ≡ Pn[∇2θ1θ1(Y1 −Q1(S1, A1; θ1))
2] is the empirical Hessian matrix. These
variance estimators will be shown in simulations presented later to have good ac-
curacy for moderate sample sizes. This success of direct inference for the estimated
parameters makes statistical inference for optimal dynamic treatment regime possible
in the multi-stage setting.
3.5 Generalization to the Multi-stage Setting
In this section, we will extend the inference procedure from the two-stage to the
more general multi-stage setting. The PQ-learning procedure for finding the optimal
dynamic treatment regime for a general U -stage setting can be summarized in 2U +1
steps as follows:
Step 1. Start from the Uth stage by minimizing the penalized Q-function at the Uth-
stage:
WU(θU) =
n∑
i=1
(YUi −QU (SUi, AUi;βU ,ψU))2 +
n∑
i=1
pλn(|ψTUSU2i|),
where pλn(·) is a pre-specified penalty function and λn is a tuning parameter.
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Step 2. Estimate the (U−1)th-stage individual pseudo-outcome by ŶU−1 = (ŶU−1,1, . . . , ŶU−1,n)T ,
where
ŶU−1,i = RU−1,i +max
a
QU(SU,i, a; θ̂U−1) = RU−1,i + β̂
T
USU1i + |ψ̂
T
USU2i|.
Step 3. Minimize the penalized Q-function in the (U − 1)th-stage with the individual
pseudo-outcome obtained from Step 2:
WU−1(θU−1) =
n∑
i=1
(ŶU−1,i −QU−1(SU−1,i, AU−1,i; θU−1))2 +
n∑
i=1
pλn(|ψTU−1SU−1,2i|).
Step 4. Estimate the (U−2)th-stage individual pseudo-outcome by ŶU−2 = (ŶU−2,1, . . . , ŶU−2,n)T ,
where
ŶU−2,i = RU−2,i +max
a
QU−1(SU−1,i, a; θ̂U−2) = RU−2,i + β̂
T
U−1SU−1,1i + |ψ̂
T
U−1SU−1,2i|.
· · ·
Step 2U+1. Estimate the first-stage parameters by least squares estimation:
θ̂1 = argminβ
1
,ψ
1
Pn(Ŷ1 −Q1(S1, A1;β1,ψ1))2 =
[
ZT1Z1
]−1
ZT1 Ŷ1.
Theorem 4 can be used backwards recursively to obtain the asymptotic distribution
of the parameters at each stage since the oracle properties can be inherited from
the prior iteration. The plug-in variance formula (11) can also be used backwards
recursively for inference for the parameters in each stage.
4 Simulation Studies
Chakraborty et al. (2009) designed a thorough simulation study of two-stage Q-
learning, which covers regular, non-regular and close-to-non-regular conditions. In
this section, we apply the proposed method to the same simulation study conditions.
Specifically, a total of n = 300 subjects are contained in the data. We set R1 = 0 and
(O1, A1, O2, A2, R2) is collected on each subject. The binary covariates Ot’s and the
binary treatments At’s are generated as follows:
P (O1 = 1) = P (O1 = −1) = 1/2,
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P (At = 1) = P (At = −1) = 1/2, t = 1, 2,
P (O2 = 1|O1, A1) = 1− P (O2 = −1|O1, A1) = expit(δ1O1 + δ2A1),
where expit(x) = exp(x)/(1 + exp(x)).
R2 = γ1 + γ2O1 + γ3A1 + γ4O1A1 + γ5A2 + γ6O2A2 + γ7A1A2 + ε,
where ε ∼ N(0, 1). The Q-functions for time t = 1, 2 are both correctly specified as:
Q2(O1, A1, O2, A2;β2,ψ2) =β21 + β22O1 + β23A1 + β24O1A1
+ ψ21A2 + ψ22O2A2 + ψ23A1A2, (12)
Q1(O1, A1;β1,ψ1) =β11 + β12O1 + ψ11A1 + ψ12O1A1. (13)
As shown in Chakraborty et al. (2009), the true values of ψ1 ≡ (ψ110, ψ120)T are given
by:
ψ110 = γ3 + q1|f1| − q2|f2|+ (1/2− q1)|f3| − (1/2− q2)|f4|,
ψ120 = γ4 + q
′
1|f1| − q′2|f2| − q′1|f3|+ q′2|f4|,
where q1 = 1/4(expit(δ1+δ2)+expit(−δ1+δ2)), q2 = 1/4(expit(δ1−δ2)+expit(−δ1−
δ2)), q
′
1 = 1/4(expit(δ1+ δ2)− expit(−δ1+ δ2)), q′2 = 1/4(expit(δ1− δ2)− expit(−δ1−
δ2)), f1 = γ5 + γ6 + γ7, f2 = γ5 + γ6 − γ7, f3 = γ5 − γ6 + γ7, f4 = γ5 − γ6 − γ7. Let
γ = (γ1, ..., γ7)
T . We consider the following six settings:
Setting 1: γ = (0, 0, 0, 0, 0, 0, 0)T , δ1 = δ2 = 0.5.
Setting 2: γ = (0, 0, 0, 0, 0.01, 0, 0)T , δ1 = δ2 = 0.5.
Setting 3: γ = (0, 0,−0.5, 0, 0.5, 0, 0.5)T , δ1 = δ2 = 0.5.
Setting 4: γ = (0, 0,−0.5, 0, 0.5, 0, 0.49)T , δ1 = δ2 = 0.5.
Setting 5: γ = (0, 0,−0.5, 0, 1, 0.5, 0.5)T , δ1 = 1, δ2 = 0.
Setting 6: γ = (0, 0,−0.5, 0, 0.25, 0.5, 0.5)T , δ1 = δ2 = 0.1.
The values of ψT20S22 for each setting are listed in Table 4.
We applied the proposed penalized Q-learning with the adaptive lasso penalized
regression to the six settings. The one-step LQA algorithm is used with least squares
estimation for the initial values. The tuning parameter λ in the adaptive lasso penalty
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Table 1: Values of ψT20S22 in the simulation studies.
S22 = (1, O2, A1)
Setting (1,1,1) (1,1,-1) (1,-1,1) (1,-1,-1)
1 0 0 0 0
2 0.01 0.01 0.01 0.01
3 1 0 1 0
4 0.99 0.01 0.99 0.01
5 2 1 1 0
6 1.25 0.25 0.25 -0.75
is chosen by five fold cross-validation. When the estimated value |ψ̂T2 S22| < 0.001, it
will be set as zero in the stage-1 estimation. The simulation results shown in Table
4 were summarized over 1000 replications. We included both the oracle estimator
and the hard-max estimator for comparison. Theoretical standard errors and 95%
confidence intervals for the hard-max estimator are not available.
Setting 1 is a completely non-regular setting, where ψT20S22 = 0 for all values of
S22. The oracle estimator automatically sets ψ̂2 = 0 and is therefore regular. It
has a very small bias, with standard errors accurately predicted by the theory and
95% confidence interval coverage close to the nominal value. The PQ estimator’s
performance is very close to the oracle estimator, with similar bias, a slightly bigger
but still well estimated standard error and similar confidence intervals.
Setting 2 is regular but very close to setting 1 with ψT20S22 all equal to 0.01.
The oracle estimator reduces to the hard-max. Although its bias is small, the oracle
estimator’s theoretical standard error is significantly overestimated and, as a result,
its confidence intervals show significant over-coverage for ψ110. On the other hand,
the PQ estimator remains consistent and its standard error estimation remains close
to the empirical values.
Setting 3 is another non-regular setting. The value of ψT20S22 is equal to 1 for half
of the subjects and equal to 0 for the other half. As expected, the oracle estimator
has the best performance in the sense of having smallest bias and standard error as
well as being precisely predicted by the theoretical standard error. The PQ estimator
has a bigger bias and standard error than the oracle estimator but the theoretical
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standard error remains close to the empirical values.
Setting 4 is a regular setting but close to Setting 3. The PQ estimator outperforms
the oracle estimator, with both a smaller bias and a smaller standard error. This phe-
nomena is consistent with findings in Setting 2, which is another nearly non-regular
setting. However, in Setting 2, we did not observe substantial overestimation of the
standard error nor over-coverage of the confidence intervals in the oracle estimator.
Setting 5 is a non-regular setting similar to Setting 3 and the performances of the
oracle and PQ estimators are very similar to their performances in Setting 3.
Setting 6 is a completely regular setting with values of ψT20S22 well above zero.
The PQ estimator has a slightly bigger bias and a slightly bigger standard error than
the oracle estimator. Both estimators’s standard errors are well predicted from the
theory.
In summary, the behavior of the PQ estimator, including its bias, theoretical
computed standard error and coverage probability of theoretically computed 95%
confidence intervals, are consistent in all six settings, whether regular or non-regular.
In non-regular or completely regular settings, PQ-learning usually has bigger bias and
larger standard error than the oracle estimator. In regular settings which are close to
non-regular cases, it has smaller bias and standard error than the oracle estimator.
Chakraborty et al. (2009) proposed several bootstrapped confidence intervals (PB:
percentile bootstrap, HB: hybrid bootstrap, DB: double bootstrap) for the hard-max
estimator as well as hard-thresholding estimators with threshold at 0.08 (HT0.08) and
0.20 (HT0.20) and soft-thresholding estimator (ST). We include their simulation results
(ψ110 only) in Table 4 for comparison. The coverage probabilities of all 10 inferential
methods in the six settings are plotted in Figure 2. The boxplot of oracle estimator,
PQ-estimator and hard-max estimator of ψ11 and ψ12 from 1000 estimates of these six
settings are provided in Figures 3 and 4 respectively. The PQ-estimator has smaller
bias and narrower inter-quantile range compared with the hard-max estimator in
most of the settings. The bias and Monte-Carlo standard deviation of the hard-max
estimator presented in Table 2 and Table 3 are similar, validating a direct comparison
between the two study results. Readers are directed to the original articles for a
discussion on the performances of different estimators and bootstrapping methods.
Briefly speaking, the bias of the hard-max estimator in Settings 3 and 4 is relatively
big. The percentile bootstrapped and hybrid bootstrapped confidence intervals can
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Table 2: Summary statistics and empirical coverage probability of 95% nominal per-
centile CIs for ψ110 and ψ120 using the oracle estimator, the proposed PQ-learning
based (PQ) estimator and the hard max (HM) estimator. Specifically, “Std-MC”
refers to the standard deviation of 1000 estimates for ψ110 or ψ120, “Std” refers to
the average of the 1000 standard error estimates and “CP” refers to the empirical
coverage probability of 95% nominal percentile confidence interval. A “*” indicates
a significantly different coverage rate other than the nominal rate.
ψ110 ψ120
Setting Bias Std-MC Std CP Bias Std-MC Std CP
1 oracle -0.0015 0.058 0.058 94.6 -0.0004 0.060 0.058 94.3
PQ -0.0013 0.060 0.061 95.1 -0.0009 0.060 0.058 94.0
HM -0.0005 0.066 − − -0.0023 0.060 − −
2 oracle -0.0025 0.065 0.075 97.5∗ 0.0003 0.056 0.059 96.3
PQ -0.0026 0.059 0.060 94.0 0.0013 0.056 0.058 96.3
HM -0.0025 0.065 − − 0.0003 0.056 − −
3 oracle -0.0032 0.071 0.071 95.3 -0.0043 0.057 0.058 94.9
PQ -0.0182 0.073 0.076 95.2 -0.0049 0.057 0.058 95.4
HM -0.0437 0.075 − − -0.0051 0.058 − −
4 oracle -0.0330 0.076 0.079 94.9 -0.0021 0.058 0.059 94.9
PQ -0.0073 0.074 0.075 95.5 -0.0022 0.058 0.058 94.8
HM -0.0330 0.076 − − -0.0021 0.058 − −
5 oracle -0.0002 0.075 0.079 95.7 0.0005 0.067 0.063 93.9
PQ -0.0188 0.079 0.080 95.3 0.0056 0.067 0.064 94.0
HM -0.0204 0.077 − − 0.0092 0.067 − −
6 oracle 0.0003 0.078 0.080 95.4 0.0009 0.063 0.062 94.8
PQ -0.0012 0.079 0.080 95.3 0.0009 0.063 0.062 94.7
HM 0.0003 0.078 − − 0.0009 0.063 − −
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correct the coverage rates for hard-thresholding and soft-thresholding estimators in
some settings. However, neither of these two bootstrapped methods can consistently
improve the coverage rate for all estimators. Overall, the soft-thresholding estimator
has the best performance with the percentile bootstrapped confidence intervals. This
is consistent with our findings for the PQ estimator due to their similar nature.
Nonetheless, we derived the theoretical formula for standard errors and therefore
did not need to rely on bootstrap method. Thus PQ-learning is substantially more
computationally efficient than the soft-thresholding approach with the bootstrap and
performs at least as well.
5 Analysis of STAR*D study
We here present the analysis of STAR*D study data using PQ-learning. STAR*D is
a prospective multi-site randomized clinical trial designed to determine the compar-
ative effectiveness of different multi-level treatment options for patients with major
depressive disorder (MDD). A total of 4041 patients (ages 18-75) with nonpsychotic
MDD were enrolled and initially treated with citalopram (CIT) (Level 1 treatment)
for a minimum of 8 weeks, with strong encouragement to complete 12 weeks in order
to maximize benefit. During this and all subsequent treatment levels, patients would
have clinic visits at weeks 0, 2, 4, 6, 9 and 12.
During all clinic visits, symptomatic status would be measured by the 16-item
Quick Inventory of Depressive Symptomatology V Clinician-Rated (QIDS-C16). Pa-
tients who did not have a satisfactory response to treatments, defined as either
< 50% reduction in QIDS-C16 or QIDS-C16 > 5, would be elligible for Level 2 treat-
ment. Seven treatment options are available at Level 2, which can be classified into
two classes, (1) Medication or Psychotherapy Switch: sertraline (SER), venlafax-
ine (VEN), bupropion (BUP) or Cognitive Psychotherapy (CT); and (2) Medication
or Psychotherapy Augmentation: CIT+BUP, CIT+buspirone (BUS) or CIT+CT.
Patients who were assigned to CT or CIT+CT in Level 2 and did not have a satis-
factory response would be elligible for Level 2A, during which they would be treated
with either VEN or BUP. Patients who did not respond satisfactorily at Level 2 and
Level 2A, if applicable, would continue to Level 3 treatment. Level 3 includes four
options: Medical Switch to mirtazapine (MIRT) or nortriptyline (NTP), and Med-
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Table 3: Summary statistics and empirical coverage probability of 95% nominal per-
centile CIs for ψ110 and ψ120 using the hard max (HM) estimator, the hard threshold
estimator with α = 0.08 (HT0.08) and α = 0.20 (HT0.20), and the soft-threshold es-
timator quoting the simulation results from Chakraborty et al. (2009). Specifically,
“Var” denotes the sample variance of 1000 estimates for ψ110 or ψ120. “PB”, “HB”
and “DB” denote percentile bootstrap, hybrid bootstrap and double bootstrap, re-
spectively. “CP” and “*” have the same meaning as given in Table 2.
Setting Estimator Bias Var CP
PB HB DB
1 HM 0.0003 0.0045 96.8∗ 93.5∗ 93.6
HT0.08 0.0017 0.0044 97.0
∗ 95.0 −
HT0.20 0.0002 0.0050 97.4
∗ 92.8∗ −
ST 0.0009 0.0036 95.3 96.1 −
2 HM 0.0003 0.0045 96.7∗ 93.4∗ 93.6
HT0.08 0.0010 0.0044 97.1
∗ 95.3 −
HT0.20 0.0003 0.0050 97.3
∗ 93.5∗ −
ST 0.0008 0.0036 95.4 95.9 −
3 HM 0.0401 0.0059 88.4∗ 92.7∗ 94.8
HT0.08 0.0083 0.0058 94.3 94.3 −
HT0.20 0.0179 0.0062 93.5
∗ 93.5∗ −
ST 0.0185 0.0055 93.4∗ 94.9 −
4 HM 0.0353 0.0059 89.6∗ 93.1∗ 94.4
HT0.08 0.0037 0.0058 94.6 94.1 −
HT0.20 0.0130 0.0062 93.9 92.8
∗ −
ST 0.0138 0.0055 94.1 95.0 −
5 HM 0.0209 0.0069 92.7∗ 93.1∗ 94.2
HT0.08 0.0059 0.0070 93.9 93.2
∗ −
HT0.20 0.0101 0.0072 93.3
∗ 93.0∗ −
ST 0.0065 0.0069 93.8 94.6 −
6 HM 0.0009 0.0067 95.0 93.8 95.0
HT0.08 0.0003 0.0081 95.1 88.5
∗ −
HT0.20 0.0011 0.0074 94.8 91.2
∗ −
ST 0.0052 0.0074 94.8 91.7∗ −
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Figure 2: Plot of coverage probabilities with all ten inference methods in six settings,
where the shaded area is 95% confidence for monte-carlo error: [93.7%, 96.3%].
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ical augmentation with either lithium or thyroid hormone added to level 2 or 2A
treatments. Patients who did not respond satisfactorily to Level 3 treatments would
continue to Level 4 treatments, which include two options: switch to tranylcypromine
or MIRT+VEN. For a complete description of STAR*D, see Fava et al. (2003) and
Rush et al. (2004).
In this analysis, for demonstration purpose, we consider a subgroup of STAR*D
patients, the 112 patients who were randomized to either BUP or SER in Level 2, had
no satisfactory response at the end of Level 2, and were then randomized to either
MIRT or NTP in Level 3. The analysis focuses on selecting the optimized treatment
regime at Level 2 and Level 3, out of the 4 unique treatment combinations. Since the
higher QIDS-C16 is, the more severe the symptom is, we define the reward as negative
of QIDS-C16 collected at the end of the Level 3. Similarly as discussed in Pineau et al.
(2007), the state variable used to tailor individual treatment is the changing rate of
QIDS-C16 during the previous treatment level. We dichotomize the changing rates at
zero. Two patients were further removed due to missing values in the reward or the
tailor variables.
Following the notations in the simulation study, let O1 and O2 be the indicator
of whether the QIDS-C16 changing rate is greater than zero in Level 1 and Level 2
respectively. Let A1 = 1 if Level 2 treatment is SER and A1 = −1 if it is BUP. Let
A2 = 1 if Level 3 treatment is NTP and A2 = −1 if it is MIRT, R2 = −QIDS −C16
collected at the end of Level 3. The Level 3 regression model is:
R2 = β21 + β22O1 + β23A1 + β24O2 + ψ21A2 + ψ22A2O1 + ψ23A2A1 + ψ24A2O2 + ε2.
Since the main effects of A1 and O2 are not statistically significant, we did not include
additional interaction terms in Level 3 model.
Table 4 shows the Level 3 regression model coefficients estimation using both
unpenalized standard least square estimation and individual penalized least square
estimation. Qualitatively, unpenalized and penalized estimations are consistent. Pa-
tients whose symptom worsened (i.e., O1 = 1 or QIDS-C16 increased) during Level 1
would have worse reward. Level 2 treatments (SER versus BUP) as well as QIDS-C16
changing rate during Level 2 show no differential effect on the final outcome. However,
the two Level 3 treatment options show significant different effects on patients with
O1 = 1 versus patients with O1 = −1. Among patients whose symptom worsened
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Table 4: Level 3 regression model coefficients estimation using both unpenalized least
square estimation and individual penalized least square estimation.
Variable unpenalized penalized
Coefficient 95% CI Coefficient 95% CI
Intercept -13.165 (-14.349, -11.981) -13.185 (-14.330, -12.039)
O1 -1.202 (-2.348, -0.057) -1.124 (-2.233, -0.015)
A1 0.004 (-0.945, 0.954) -0.046 (-0.967, 0.874)
O2 -0.587 (-1.605, 0.431) -0.554 (-1.533, 0.425)
A2 -1.276 (-2.460, -0.092) -1.266 (-2.239, -0.292)
O1A2 -1.621 (-2.766, -0.475) -1.300 (-2.410, -0.191)
A1A2 0.535 (-0.414, 1.484) 0.052 (-0.775, 0.880)
O2A2 0.278 (-0.740, 1.297) 0.017 (-0.748, 0.783)
in Level 1, NTP further worsened their symptom when compared to MIRT. Among
patients whose symptom improved in Level 1, NTP and MIRT show no obvious dif-
ference as to the final outcome.
Quantitatively, the penalized estimator has smaller standard errors in the coef-
ficient estimation of ψ2 = (ψ21, ψ22, ψ23, ψ24)
T than the unpenalized estimator. In
addition, the penalized estimator dramatically shrinks coefficients of the two unim-
portant predictors A1A2 and O2A2 toward zero. On the other hand, these two es-
timators are similar in the coefficient estimation of β2 = (β21, β22, β23, β24)
T , which
is expected since the penalty is imposed only on ψ2. In order to shrink coefficients
of the unimportant predictors A1 and O2, one can further impose penalty on |β2|,
which will not be implemented in this work. The lack of effect of A1 and O2 is
actually expected since we include in this analysis only patients eligible for Level 3
treatment, in other words, only patients who did not respond satisfactorily to Level 2
treatment. This inclusion criteria is imposed because our current framework is built
on the situation where all patients will be treated in both stages. The extension to
cases where patients may be cured during intermediate stages and hence not eligible
for subsequent treatment stages is not trivial and will be considered in future work.
Table 5 shows the estimated values of |ST22ψ2|, where S22 = (1, O1, A1, O2)T . When
O1 = −1, Level 3 treatment effect is small but the unpenalized estimator shows
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Table 5: Values of |ST22ψ̂2| in STAR*D study.
|ST22ψ̂2|
O1 A1 O2 Unpenalized Penalized
-1 -1 -1 0.468 0.035
-1 -1 1 0.088 0.000
-1 1 -1 0.601 0.070
-1 1 1 1.158 0.105
1 -1 1 3.153 2.601
1 1 -1 2.640 2.531
1 -1 -1 3.710 2.636
1 1 1 2.083 2.496
Table 6: Level 2 regression model coefficients estimation using both Hard-max and
PQ-learning.
Hard-Max PQ-learning
Variable Coefficient Hybrid 95% CI Coefficient 95% CI
Intercept -11.063 (-12.482, -10.095) -11.612 (-13.076, -10.149)
O1 0.263 (-0.764, 1.547) 0.313 (-1.114, 1.740)
A1 -0.119 (-1.120, 0.884) -0.038 (-1.115, 1.039)
O1A1 -0.448 (-1.079, 0.251) -0.085 (-0.830, 0.661)
significant bias from zero. On the other hand, the penalized estimator successfully
shrinks the value of |ST22ψ2| in all groups close to zero. Although due to the limitation
of current LQA algorithm, the penalized estimator cannot exactly set |ST22ψ2| to zero,
the bias is significantly smaller than unpenalized estimator. When (O1, A1, O2) =
(−1,−1, 1), the penalized estimation of |ST22ψ2| falls below the preselected cutoff of
0.001 and is shown as 0 in Table 5. When O1 = 1, the treatment option MIRT can
significantly improve the symptom. Since A1 and O2 have no important effect on the
outcome, we expect similar treatment effects among the four groups with O1 = 1.
From this point of view, the unpenalized estimator is inferior since it shows much
bigger variation than the penalized estimator.
We next consider the Level 2 regression model. The pseudo-outcome Ŷ is defined
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by Ŷ = βT2 S21 + |ψT2 S22| and we impose the following Level 2 model
Ŷ = β11 + β12O1 + β13A1 + β14O1A1.
Table 6 shows the Level 2 model coefficient estimation using both Hard-max and
PQ-learning. The coeffiecients estimations for the intercept and O1 are similar from
two different estimation methods. While in the estimation of cofficients for A1 and
O1A1, PQ-learning’s estimation is significantly towards zero. Based on 95% CI from
PQ-learning, O1, A1 have no effect on the pseudo-outcome. Since A1 shows no effect
in Level 3 regression either, it is easy to interpret its lack of effect on pseudo-outcome.
In contrast, O1 is a strong predictor in Level 3 treatment. Its lack of effect in Level
2 regression may be explained as follows. In Level 3 regression, the O1 = 1 group’s
reward is smaller than the O1 = −1 group’s reward by 2β22 ≈ 2.24. However, the
optimal Level 3 treatment can increase the O1 = 1 group’s reward by |ψT2 S22| ≈ 2.6
but cannot increase the O1 = −1’s reward. Combined together, O1 has no effect on
the pseudo-outcome.
Our analysis found that the optimal Level 2 and Level 3 treatment regime is
following. If a patient’s symptom worses in Level 1 and remains unsatisfactory in
Level 2, MIRT is a better option for Level 3 treatment when compared to NTP. If a
patient’s symptom improves in Level 1 and remains unsatisfactory in Level 2, MIRT
or NTP have similar effect as Level 3 treatment.
6 Discussion
In this article, we propose a penalized Q-learning framework and an individual se-
lection procedure for developing optimal dynamic treatment regimes. Statistical in-
ference for parameters at each stage are established. The long-term difficulty in
developing optimal dynamic treatment regimes—non-regularity associated with the
treatment effect parameters—is solved. The methods are shown to be effective and
the standard errors are estimated computationally efficiently and with good accuracy.
The proposed concept of individual selection is generally applicable. Specifically,
the Q-learning approach is an inefficient special case of the doubly robust structural
nested mean model (drSNMM) proposed by Robins (2004). The drSNMM is an
estimating equation approach, which also has the difficulty of non-regularity. The
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PQ-learning approach proposed here can be straightforwardly extended to penalized
drSNMM to handle the non-regularity issue.
Although the linear model form of the Q-functions presented here is an important
first step, as well as being useful for illustrating the ideas of this paper, this form
may not be sufficiently flexible for certain practical settings. Semiparametric models
are a potentially very useful alternative in many such settings because such models
involve both a parametric component which is usually easy to interpret and a non-
parametric component which allows greater flexibility. Generalizations of Q-functions
to allow diverse data such as ordinal outcome, censored outcome and semiparametric
modeling, are thus future research topics of practical importance.
The current theoretical framework is based on discrete covariates. This condition
is not as restricted as it looks. For example, in a practical two-stage setting where
continuous covariates are presented, unless in the rare case where the parameter
ψ20 is zero, the “problematic” set Mc⋆ = {i : ψT20S22i = 0} will not have positive
probability. Having said that, we can always discretize the continuous covariates into
several strata and apply the proposed methods with these strata. Obviously, there
will be loss of information with this approach. Future research to extend our work to
continuous covariates would also be very useful in practice. Likewise, the current PQ-
learning framework works for two-level treatments. The generalization to multilevel
treatments will be a natural and useful next step.
In many clinical studies, the state space is often of very high dimension. To
develop optimal dynamic treatment regimes in this case, it will be important to
develop simultaneous variable selection (for state variables) and individual selection.
More modern machine learning techniques such as support vector regression and
random forests can be nested into our PQ-learning framework as powerful tools to
develop optimal dynamic treatment regimes.
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